Trademark: 85337157
Status Date
Monday, January 19, 2015
Filing Date
Friday, June 3, 2011
Published for Opposition
Tuesday, October 18, 2011
Abandoned Date
Monday, January 19, 2015
5 Human pharmaceuticals for the treatment of anti-viral diseases, auto-immune and inflammatory diseases, cardiovascular diseases, central nervous system diseases, pain, dermatologic disorders, infectious-related diseases, metabolic diseases, gastrointestinal diseases, muscle dystonias, wrinkles and smooth muscle disorders, oncologic diseases, ophthalmic diseases, respiratory diseases; vaccines; and hemostatic agents
Jan 20, 2015
Abandonment Notice Mailed - No Use Statement Filed
Jan 19, 2015
Abandonment - No Use Statement Filed
May 16, 2014
Notice Of Approval Of Extension Request E-Mailed
May 15, 2014
Extension 5 Granted
May 12, 2014
Extension 5 Filed
May 12, 2014
Teas Extension Received
Nov 28, 2013
Notice Of Approval Of Extension Request E-Mailed
Nov 27, 2013
Extension 4 Granted
Nov 21, 2013
Extension 4 Filed
Nov 21, 2013
Teas Extension Received
May 11, 2013
Notice Of Approval Of Extension Request E-Mailed
May 10, 2013
Extension 3 Granted
May 8, 2013
Extension 3 Filed
May 8, 2013
Teas Extension Received
May 8, 2013
Teas Change Of Correspondence Received
Oct 13, 2012
Notice Of Approval Of Extension Request E-Mailed
Oct 12, 2012
Extension 2 Granted
Oct 11, 2012
Extension 2 Filed
Oct 11, 2012
Teas Extension Received
Jun 28, 2012
Notice Of Approval Of Extension Request E-Mailed
Jun 27, 2012
Extension 1 Granted
Jun 4, 2012
Extension 1 Filed
Jun 27, 2012
Case Assigned To Intent To Use Paralegal
Jun 4, 2012
Teas Extension Received
Jun 1, 2012
Teas Change Of Correspondence Received
Dec 13, 2011
Noa Mailed - Sou Required From Applicant
Oct 18, 2011
Published For Opposition
Sep 28, 2011
Notice Of Publication
Sep 13, 2011
Approved For Pub - Principal Register
Sep 8, 2011
Assigned To Examiner
Jun 7, 2011
New Application Office Supplied Data Entered In Tram
Jun 7, 2011
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
